← Back to Search

Procedure

Proximal femur fractures with ORIF for Hip Fracture

N/A
Waitlist Available
Led By Michael Blauth, Professor
Research Sponsored by AO Clinical Investigation and Publishing Documentation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

An expert panel of surgeons agreed that there is not any established, standardized approach to the teaching of intraoperative imaging and that there may be practice gaps in decision making and the use of imaging among trauma surgeons. The panel is set to initiate a consensus-based evaluation process to develop a list of criteria for assessing images and would like to validate these criteria for differentiating good quality versus poor quality images in term of reliability and accuracy.

Eligible Conditions
  • Hip Fracture

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Proximal femur fractures with ORIFExperimental Treatment1 Intervention
Proximal femur fractures treated with ORIF
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ORIF
2011
N/A
~420

Find a Location

Who is running the clinical trial?

AO Clinical Investigation and Publishing DocumentationLead Sponsor
60 Previous Clinical Trials
13,529 Total Patients Enrolled
2 Trials studying Hip Fracture
275 Patients Enrolled for Hip Fracture
Michael Blauth, ProfessorPrincipal InvestigatorMedical University Innsbruck
2 Previous Clinical Trials
317 Total Patients Enrolled
~15 spots leftby Nov 2025